HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension.

Abstract
Twenty three patients with essential hypertension who were uncontrolled on diuretic and/or beta-receptor antagonist therapy were treated additionally with the vasodilator, pinacidil, in an open study. Significant reduction in mean blood pressure was achieved. Supine and erect systolic and diastolic blood pressure fell by 44/25 mmHg and 37/24 mmHg respectively over the study period of 12 weeks. Side-effects such as dizziness, headache, facial flushing and mild oedema were experienced by 10 patients during the study, all of which were mild and transient and did not require withdrawal from pinacidil therapy. Pinacidil is an effective and well tolerated agent in the treatment of essential hypertension.
AuthorsV D'Arcy, M Laher, D McCoy, P Sullivan, C H Walsh, M P Hickey
JournalEuropean journal of clinical pharmacology (Eur J Clin Pharmacol) Vol. 28 Issue 3 Pg. 347-9 ( 1985) ISSN: 0031-6970 [Print] Germany
PMID4007040 (Publication Type: Journal Article)
Chemical References
  • Guanidines
  • Vasodilator Agents
  • Pinacidil
Topics
  • Adult
  • Aged
  • Blood Pressure (drug effects)
  • Female
  • Guanidines (adverse effects, therapeutic use)
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Middle Aged
  • Pinacidil
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: